Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

MNMD Mind Medicine MindMed Inc

6,495

0,00 (0,00%)

14 Jan 2025 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/26/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Carrie Liao

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Mind Medicine MindMed (NASDAQ:MNMD)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025

Plus de graphiques de la Bourse Mind Medicine MindMed

Mind Medicine MindMed (NASDAQ:MNMD)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025

Plus de graphiques de la Bourse Mind Medicine MindMed

Actualités Mind Medicine MindMed Inc

Form 8-K - Current report
Lundi 13 Janvier 2025 ( il y a 20 heures) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 27 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 27 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 27 Décembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 26 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 26 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 26 Décembre 2024 ( il y a 3 semaines) • Edgar (US Regulatory)

MindMed to Be Added to the Nasdaq Biotechnology Index
Jeudi 19 Décembre 2024 ( il y a 4 semaines) • Business Wire

Form 8-K - Current report
Lundi 16 Décembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
Lundi 16 Décembre 2024 ( il y a 4 semaines) • Business Wire

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
Mercredi 11 Décembre 2024 ( il y a 1 mois) • Business Wire

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
Jeudi 5 Décembre 2024 ( il y a 1 mois) • Business Wire

Plus d'articles sur Mind Medicine MindMed Inc

Jpmorgan Chase Financial...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales